- NSE
- BIOCON
- BSE
- 532523
- ISIN
- INE376G01013
BIOCON
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹370.95
+₹2.90 (+0.79%)
NSE close ·
BIOCON closed at ₹370.95 on 12 Nov 2026, up 0.79% on the day, and is down 8.61% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹323.50 to ₹440.70.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹60,454 Cr
- P/E (TTM)
- 124.5
- Industry P/E
- 35.0
- EPS (TTM)
- ₹2.98
- P/B
- 1.74
- Book value
- ₹213.80
- ROE
- 1.3%
- ROCE
- 2.5%
- Debt/equity
- 0.43
- Operating margin
- 5.7%
- Net margin
- 2.6%
- Dividend yield
- 0.13%
Market cap, P/E, P/B and yield at the 12 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +5.70% | +7.86% |
| Net profit | −55.37% | −21.94% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹4,423 Cr | ₹56.70 Cr | −57.30% | ₹0.25 |
| Jun 2026 | ₹4,391 Cr | ₹137 Cr | +53.36% | ₹0.87 |
| Mar 2026 | ₹4,569 Cr | ₹199 Cr | −56.77% | ₹0.79 |
| Dec 2025 | ₹4,290 Cr | −₹51.80 Cr | −163.87% | ₹1.07 |
| Sep 2025 | ₹4,389 Cr | ₹133 Cr | +390.04% | ₹0.65 |
| Jun 2025 | ₹4,022 Cr | ₹89.20 Cr | −89.65% | ₹0.26 |
| Mar 2025 | ₹4,454 Cr | ₹459 Cr | +106.10% | ₹2.87 |
| Dec 2024 | ₹3,856 Cr | ₹81.10 Cr | −89.23% | ₹0.21 |
Armor risk check
BIOCON moves about 1.7× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is BIOCON's share price today?
BIOCON (NSE: BIOCON) closed at ₹370.95 on 12 Nov 2026, up 0.79% from the previous close of ₹368.05. It traded between ₹365.10 and ₹372.20 that day.
What are BIOCON's 52-week high and low?
Over the last 52 weeks BIOCON traded between ₹318.40 and ₹447.15, adjusted for splits and bonuses.
What are BIOCON's NSE symbol, BSE code and ISIN?
BIOCON has NSE symbol BIOCON, BSE code 532523, ISIN INE376G01013.
How has BIOCON performed over 1, 3 and 5 years?
BIOCON's share price return: 1Y −8.61%, 3Y +17.72% a year, 5Y +1.38% a year. Dividends are not included.
Does BIOCON pay a dividend?
Yes. BIOCON's latest dividend went ex on 3 Jul 2026: Final · ₹0.50 per share. Dividends over the past year come to a yield of 0.13% at the latest close.
What is BIOCON's P/E ratio?
BIOCON's P/E ratio is 124.5: the ₹370.95 close on 12 Nov 2026 over trailing twelve-month EPS of ₹2.98 (consolidated, four quarters to 30 Sep 2026).
What is BIOCON's market cap?
BIOCON's market cap is ₹60,454 Cr at the close on 12 Nov 2026.
Which sector is BIOCON in?
BIOCON is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how BIOCON fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app